Marvel Studios Eyeing Sam Raimi to Return for ‘Doctor Strange 3’

Following Scott Derrickson‘s departure from Doctor Strange in the Multiverse of Madness, Sam Raimi stepped in to take the reigns and put together one of Marvel Studios’ best Phase 4 films. Raimi infused the film with his signature style, providing audiences with a giant walking eyeball, a zombie Doctor Strange and a reminder that Marvel Studios films can be both “comic booky” and fun. Rumors have begun to swirl that Stephen Strange has a major role to play in the Multiverse Saga and that the studio is keen on pushing out another Doctor Strange solo film sooner rather than later and now that they might just have Raimi in their sights to helm it.

During a segment of the Hot Mic Podcast, co-host Jeff Sneider indicated that it’s his belief that Raimi will return to direct the third installment in the Doctor Strange franchise. Though Sneider was clear that he was not confirming Raimi’s return, he hinted that it was pretty clear that was the direction things were headed.

Doctor Strange in the Multiverse of Madness grossed just short of $1B at the box office ($955.8M), making it the fourth highest-grossing film of 2022. The film’s post-credit scene, which introduced Charlize Theron as Clea, hinted at Strange playing a major role in the larger narrative of the Multiverse Saga and recent rumors have suggested that the character will essentially fill the shoes Tony Stark wore towards the end of the Infinity Saga.

Despite the rumors, Marvel Studios has not officially announced the Doctor Strange threequel; in fact, Disney Chairman Bob Iger recently indicated that the studio may be less inclined to revisit characters for a “third and a fourth” film in the future in favor of bringing new characters to the screen. Additionally, news of a slow down and increased measures of quality control within Marvel Studios don’t seem to match up with the rumored “fast-tracking” of Doctor Strange 3. Disney will be in attendance at April’s CinemaCon, providing them with an opportunity to publicly address any additions, subtractions or delays to Marvel Studios’ slate, should they chose to do so. Otherwise, fans may have to wait until SDCC ’23, or later, to see what Iger’s return to the company means for Marvel Studios theatrical plan.

Source: YouTube

Previous Post
chang can dunk review

REVIEW: ‘Chang Can Dunk’ is Worth a Shot

Next Post

Jenna Ortega Circling a Role in ‘Beetlejuice 2’

Related Posts